Table 2.
Prevalence of CNS Medication Use and Dose Information Over Time*
CNS Medication Use | Year 1 (N = 3,055), % | Year 2 (N = 2,911), % | Year 3 (N = 2,693), % | Year 5 (N = 2,480), % |
Use of 2+ agents | 2.98 | 3.85 | 4.34 | 4.29 |
Use of 1 agent | 10.90 | 10.55 | 11.96 | 13.74 |
High-dose use (>3 SDD) | 2.39 | 2.85 | 3.04 | 3.43 |
Medium-dose use (1–3 SDD) | 3.50 | 4.19 | 5.76 | 6.33 |
Low-dose use (<1.0 SDD) | 7.99 | 7.46 | 7.50 | 8.27 |
Long-term use | 7.79 | 10.07 | 11.33 | 11.33 |
Short-term use | 6.09 | 4.43 | 4.98 | 6.69 |
Notes CNS = central nervous system; SDD = summated standard daily dose.
Test of trend using GENMOD in SAS; χ2 = 21.12, df = 1; p < .001.